Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repaglinide + Bedtime Insulin vs Biphasic Insulin 30 in T2DM
NCT00799448Phase 4Terminated
- Sponsor
- Novo Nordisk
- Start
- Sep 2003
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2003; status: terminated.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00799448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799448.